Literature DB >> 8442944

Prognostic significance of epidermal growth factor receptor in squamous cell carcinoma of the maxillary sinus.

M Miyaguchi1, S Sakai, J Olofsson, H Kuwabara, H Sakamoto.   

Abstract

The expression of epidermal growth factor receptor (EGFR) was determined immunohistochemically in two groups of maxillary sinus squamous cell carcinomas, one with recurrences at the primary site after combination therapy with radiotherapy, chemotherapy and/or surgery and one without local recurrences. Using a four-graded scale (-, +, + +, + + +), 9 of the 10 recurrent carcinomas had a staining intensity and proportion of stained cells of + + or more. A comparable staining intensity was found in 9 of the 18 non-recurrent carcinomas. This difference is statistically significant (Fisher's exact probability test, P < 0.05). These results indicate that an increased expression of EGFR may influence the recurrence rate of squamous cell carcinoma of the maxillary sinus after combined therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8442944     DOI: 10.1007/bf00168859

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  30 in total

1.  Expression of epidermal growth factor receptor in laryngeal dysplasia and carcinoma.

Authors:  M Miyaguchi; J Olofsson; H B Hellquist
Journal:  Acta Otolaryngol       Date:  1990 Sep-Oct       Impact factor: 1.494

2.  Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal.

Authors:  S COHEN
Journal:  J Biol Chem       Date:  1962-05       Impact factor: 5.157

3.  Growth-inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture.

Authors:  N Kamata; K Chida; K Rikimaru; M Horikoshi; S Enomoto; T Kuroki
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

4.  Expression of epidermal growth factor receptor on oral squamous cell carcinoma.

Authors:  M Partridge; W J Gullick; J D Langdon; M Sherriff
Journal:  Br J Oral Maxillofac Surg       Date:  1988-10       Impact factor: 1.651

5.  Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.

Authors:  E M Messing
Journal:  Cancer Res       Date:  1990-04-15       Impact factor: 12.701

6.  Effects of epidermal growth factor receptor concentration on tumorigenicity of A431 cells in nude mice.

Authors:  J B Santon; M T Cronin; C L MacLeod; J Mendelsohn; H Masui; G N Gill
Journal:  Cancer Res       Date:  1986-09       Impact factor: 12.701

7.  Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours.

Authors:  D E Neal; C Marsh; M K Bennett; P D Abel; R R Hall; J R Sainsbury; A L Harris
Journal:  Lancet       Date:  1985-02-16       Impact factor: 79.321

8.  Characterization and quantitation of the epidermal growth factor receptor in invasive and superficial bladder tumors.

Authors:  K Smith; J A Fennelly; D E Neal; R R Hall; A L Harris
Journal:  Cancer Res       Date:  1989-11-01       Impact factor: 12.701

9.  Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck.

Authors:  J Ishitoya; M Toriyama; N Oguchi; K Kitamura; M Ohshima; K Asano; T Yamamoto
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

10.  Increased EGF receptors on human squamous carcinoma cell lines.

Authors:  G P Cowley; J A Smith; B A Gusterson
Journal:  Br J Cancer       Date:  1986-02       Impact factor: 7.640

View more
  2 in total

1.  Expression of epidermal growth factor receptor in the inverted papilloma and squamous cell carcinoma of nasal cavity.

Authors:  Jiung-Chih Chao; Sheen-Yie Fang
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-01-30       Impact factor: 2.503

2.  A correlation of argyrophilic nucleolar organizer regions with prognoses in patients with maxillary sinus squamous cell carcinoma.

Authors:  M Miyaguchi; T Kawahara; S Sakai; H Kuwabara; H Sakamoto
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.